Search results for

Our lives, our cultures, are composed of many overlapping stories. Writer Chimamanda Adichie warns that if we hear only a single story about another person, we risk a critical misunderstanding.

In 2011, a company called Oasis Research sued more than a dozen tech companies it said were violating its patent for online data backup. Now that the litigation has ended, we get a rare look inside the world of patent lawsuits and find out just how much money was at stake.

Guest host Celeste Headlee and editor Ammad Omar crack open the listener mailbox for backtalk.

The White House says the NSA needs to collect citizens' phone records to protect the country from terrorist threats. But is it in our best interests or just another example of Big Brother? The Barbershop guys weigh in.

Leaders from around the world are urging Syrian opposition and government groups to hold talks aimed at ending the two-year-old civil war there. But the Syrian opposition won't commit to negotiations. Guest host Celeste Headlee speaks with Khalid Saleh, Chief Spokesperson for the Syrian Opposition recognized by the US.

June means graduation, but walking across the stage is creating anxiety for new grads looking for jobs. Guest host Celeste Headlee speaks with NPR Senior Business Editor Marilyn Geewax, and The Wall Street Journal's Sudeep Reddy about Friday's job numbers, and how the hunt is going for recent graduates.

In 2011, Comet Lovejoy traveled through the sun's corona and lived to tell the tale. But its tail was the most telling. Reporting in the journal Science, Cooper Downs, an astrophysicist at Predictive Science Inc., says that the wiggly path of the comet's tail helps explain the sun's magnetic field.

Scenes of destroyed homes and businesses were common following the recent Oklahoma tornadoes. David Prevatt, a structural engineer at the University of Florida, says that improving resistance to tornadoes will require better building materials and techniques, plus a strong dose of political will.

When doctors run out of clues on how to treat a cancer patient, they sometimes order a scan of all the patient's genes. But such a test can turn up unexpected results, such as greater risk of another disease. When are doctors obligated to tell the patient what they know? And do patients have the right not to know?